|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
03/21/2024 |
$5.50 |
$5.87 |
$5.45 |
$5.49 |
2.73M | 03/22/2024 |
$5.51 |
$5.51 |
$5.01 |
$5.01 |
3.30M | 03/25/2024 |
$5.00 |
$5.08 |
$4.84 |
$4.91 |
2.83M | 03/26/2024 |
$5.01 |
$5.15 |
$4.99 |
$5.01 |
3.16M | 03/27/2024 |
$5.04 |
$5.21 |
$4.97 |
$5.15 |
2.99M |
|
BioCryst Pharmaceuticals is a commercial-stage biotechnology company that discovers oral, small-molecule medicines. Co. focuses on oral treatments for rare diseases. Co.'s drug/drug candidates include: ORLADEYO (berotralstat), an oral serine protease inhibitor targeting kallikrein that is being developed for the prevention of Hereditary Angioedema attacks; BCX9930, an oral factor D inhibitor for the treatment of complement-mediated diseases; BCX9250, an oral activin receptor-like kinase-2 inhibitors for the treatment of fibrodysplasia ossificans progressive; and RAPIVAB® (peramivir injection), an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza. | |
|
BioCryst Pharmaceuticals (BCRX) has the following price history information. Looking back at BCRX historical stock prices for the last five trading days, on March 21, 2024, BCRX opened at $5.50, traded as high as $5.87 and as low as $5.45, and closed at $5.49. Trading volume was a total of 2.73M shares. On March 22, 2024, BCRX opened at $5.51, traded as high as $5.51 and as low as $5.01, and closed at $5.01. Trading volume was a total of 3.30M shares. On March 25, 2024, BCRX opened at $5.00, traded as high as $5.08 and as low as $4.84, and closed at $4.91. Trading volume was a total of 2.83M shares. On March 26, 2024, BCRX opened at $5.01, traded as high as $5.15 and as low as $4.99, and closed at $5.01. Trading volume was a total of 3.16M shares. On March 27, 2024, BCRX opened at $5.04, traded as high as $5.21 and as low as $4.97, and closed at $5.15. Trading volume was a total of 2.99M shares.
BCRX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into BioCryst Pharmaceuticals shares, starting with a $10,000 purchase of BCRX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$10.58 |
|
End price/share: |
$5.15 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-51.32% |
|
Average Annual Total Return: |
-6.95% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$4,866.87 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
03/21/2024 | $5.49 | 03/22/2024 | $5.01 | 03/25/2024 | $4.91 | 03/26/2024 | $5.01 | 03/27/2024 | $5.15 |
|
|